Skip to content
HowShorted

Tyra Biosciences, Inc. short interest in 2022

In 2022, Tyra Biosciences, Inc.'s disclosed short interest ran from 4.38% of shares outstanding on 14 Jan 2022 to 3.01% on 30 Dec 2022, a change of -1.37 percentage points. The year's high was 5.66% on 15 Mar 2022 and its low 3.01% on 30 Dec 2022, averaging 4.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 59.96 days on 30 Dec 2022. Full history: Tyra Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tyra Biosciences, Inc. in 2022

2022 in figures

Start of year
4.38% (14 Jan 2022)
End of year
3.01% (30 Dec 2022)
Change
-1.37 pp
High
5.66% (15 Mar 2022)
Low
3.01% (30 Dec 2022)
Average
4.44%
Highest days to cover
59.96 (30 Dec 2022)
SEC filings marked
8

Every report in 2022

Tyra Biosciences, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20224.38%15.44
31 Jan 20224.69%12.84
15 Feb 20224.61%23.16
28 Feb 20224.89%21.07
15 Mar 20225.66%12.1310-K filed, results (8-K)
31 Mar 20225.53%21.17
14 Apr 20225.47%41.99
29 Apr 20225.03%26.65
13 May 20224.74%36.9810-Q filed, results (8-K)
31 May 20224.61%34.43
15 Jun 20224.69%35.71
30 Jun 20224.65%22.91
15 Jul 20224.58%25.94
29 Jul 20224.57%44.51
15 Aug 20224.49%44.8910-Q filed, results (8-K)
31 Aug 20224.10%43.77
15 Sep 20224.07%46.27
30 Sep 20224.12%42.41
14 Oct 20224.03%44.48
31 Oct 20223.92%43.98
15 Nov 20223.67%30.7010-Q filed, results (8-K)
30 Nov 20223.63%14.32
15 Dec 20223.53%31.38
30 Dec 20223.01%59.96

See also: Tyra Biosciences, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.